Edmond De Rothschild Holding S.A. Eli Lilly & CO Call Options Transaction History

Edmond De Rothschild Holding S.A.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $4.15 Million - $5.55 Million	-7,000 Reduced 46.67%	8,000 $6.22 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $7.88 Million - $9.29 Million	15,000 New	15,000 $8.74 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $1.58 Million - $2.11 Million	4,500 Added 34.62%	17,500 $8.21 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $4.04 Million - $4.74 Million	13,000 New	13,000 $4.46 Million
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $1.19 Million - $1.35 Million	4,000 New	4,000 $97,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.